跳至主要内容
临床试验/ACTRN12623000502639
ACTRN12623000502639招募中3 期

A double-blind, randomised, placebo-controlled trial to evaluate the effect of oral Melatonin administered to nulliparous women at 39 weeks' gestation, on the rate of induction of labour.

Curtin University0 个研究点目标入组 530 人开始时间: 2023年5月17日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
530

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
Female

入选标准

  • Nulliparous women aged 16 years and over, with a singleton pregnancy in cephalic presentation, without clinical indication for induction, awaiting spontaneous onset of labour, not planning a scheduled birth before 41 weeks unless indicated and able to provide written informed consent to participate in the clinical trial.

排除标准

  • Women with indications for induction of labour or caesarean section prior to 41 weeks because of medical complications; any fetal congenital abnormality or known fetal compromise that would necessitate admission to NICU after birth; any known sensitivity or adverse reaction to melatonin.

研究者

相似试验